Marker Therapeutics (MRKR) Return on Capital Employed [ROCE] (2016 - 2026)
Marker Therapeutics' Return on Capital Employed [ROCE] came in at -78.84% for Q2 2026, up 62.00 percentage points from -140.84% a year earlier and up 11.59 percentage points from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Return on Capital Employed [ROCE] (2016 - 2026) Analysis & Trends
For FY2025, Marker Therapeutics' Return on Capital Employed [ROCE] was -70.54%, down 1.53 percentage points from FY2024.
- Return on Capital Employed [ROCE] has declined in each of the last three years, though with a five-year change of +2.43 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -69.01% in FY2024 (-4.78 pp), -64.24% in FY2023 (-18.74 pp), -45.50% in FY2022 (+44.28 pp) and -89.78% in FY2021 (-16.81 pp).
- The five-year range for quarterly Return on Capital Employed [ROCE] is -140.84% (Q2 2025) to -56.23% (Q3 2021).
- Year-over-year, Return on Capital Employed [ROCE] increased in five of the last eight quarters, with an average year-over-year change of +2.47 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2026 (a gain of 62.00 percentage points), and the weakest in Q3 2024 (a drop of 48.34 percentage points).
- Business Quant data shows MRKR's Return on Capital Employed [ROCE] at -90.43% (Q1 2026), -77.78% (Q4 2025) and -107.87% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Marker Therapeutics | 17.53 Mn | -42.37 Mn | - | -78.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -78.84% |
| Mar 31, 2026 | -90.43% |
| Dec 31, 2025 | -77.78% |
| Sep 30, 2025 | -107.87% |
| Jun 30, 2025 | -140.84% |
| Mar 31, 2025 | -79.54% |
| Dec 31, 2024 | -85.51% |
| Sep 30, 2024 | -130.17% |
| Jun 30, 2024 | -100.77% |
| Mar 31, 2024 | -96.35% |
| Dec 31, 2023 | -95.73% |
| Sep 30, 2023 | -81.83% |
| Jun 30, 2023 | -78.58% |
| Mar 31, 2023 | -71.00% |
| Dec 31, 2022 | -79.80% |
| Sep 30, 2022 | -86.52% |
| Jun 30, 2022 | -86.77% |
| Mar 31, 2022 | -75.93% |
| Dec 31, 2021 | -69.09% |
| Sep 30, 2021 | -56.23% |
API Access
Marker Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();